Search Results
An AI-derived digital pathology-based biomarker to predict the benefit of ADT in PC with validat...
AI-derived pathology-based biomarker predicts benefit of LTADT with RT in localised high-risk PC
AI biomarker predicts benefit of long-term ADT in prostate cancer
Advances in digital pathology and artificial intelligence for prostate cancer
An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer
AI for Pathology - Professor Nasir Rajpoot
AI Unlocks Prostate Cancer Treatment Benefits
23-10 Daniel Spratt, MD "Modern-Day Radiation Therapy and Personalizing Hormone Therapy Use with AI"
AI's Role in Predicting Cancer Treatment Outcomes with Dr. Showalter | TCP Ep. 73
Biomarkers & Personalized Medicine with Dr. Daniel Spratt - ZERO Prostate Cancer Summit 2022
MedAI Session 14: Frontiers of Medical AI - Therapeutics and Workflows | Andre Esteva
Digital Pathology 3.0 Webinar
